Pills masthead

News Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009

2008200720062004

Aug 20, 2018
--Company Announces Preliminary Fiscal 2018 Fourth-Quarter and Full-Year Financial Results; To Host Conference Call Today at 8 a.m. ET--

Lannett Company, Inc. (NYSE: LCI) today said that its distribution agreement with Jerome Stevens Pharmaceuticals (JSP), which expires on March 23, 2019, will not be renewed. "The Steinlauf family...

More
Aug 3, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive perpetual licensing agreement with Andor Pharmaceuticals, LLC for Methylphenidate Hydrochloride Extended...

More
Jul 23, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018. The June product...

More
Jun 29, 2018

Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost reduction plan of its subsidiary, Cody Laboratories (Cody), a developer and manufacturer of pain management active...

More
Jun 1, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Levofloxacin Oral...

More
May 21, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dronabinol Capsules...

More
May 7, 2018
--Adjusted EPS Higher Than Expected; Outlook for Fiscal 2018 Net Sales and Adjusted Profitability Affirmed--

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2018 third quarter ended March 31, 2018. "We continue to make good progress executing on our strategic...

More
May 7, 2018
--Transaction Includes 23 Approved and 1 Pending Drug Product Applications, Primarily Oral Solutions--

Lannett Company, Inc. (NYSE: LCI) today announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International plc for an upfront payment plus...

More
May 3, 2018

Lannett Company, Inc. (NYSE: LCI) today announced its participation at two upcoming investor conferences. Schedule below: Deutsche Bank 43rd Annual Health Care Conference at 9:20 a.m. ET, on...

More
May 2, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2018 third quarter on Monday, May 7, 2018, after the market closes. Lannett management will...

More
 
Price Data
NYSELCI